Oncology - European Medical Journal

This site is intended for healthcare professionals

Continue

Oncology

Filter
EMJ Oncology 10 [Supplement 4] 2022 Feature Image
7 Mins
24 Feb 2022

Evolving the Role for Immunotherapy in Lung Cancer: Extensive-Stage Small Cell Lung Cancer and Unresectable Stage III Non-small Cell Lung Cancer

Lung cancer is classified into NSCLC (85% of patients) and SCLC (15%). NSCLC can be further classified histologically into three main type…
11 Mins
18 Feb 2022

New Developments, Data, and Guideline Updates: Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism Associated with Cancer – Interviews with Key Opinion Leaders

CAT is a serious complication that can affect up to 6% of patients with cancer, and is associated with a 2–5-fold increased risk of…
EMJ Oncology 10 [Supplement 2] 2022 feature
14 Mins
3 Feb 2022

Optimising Cholangiocarcinoma Diagnosis and Treatment Focusing on Precision Medicine

This article is based on interviews conducted with Lorenza Rimassa, Arndt Vogel, and Harpreet Wasan. They provided their expert opinion…
10 Mins
21 Jan 2022

Increasing Therapy Options in Solid Tumours: A Consideration of Testing Methodologies in Non-small Cell Lung Cancer and Breast Cancer

Lung cancer has a devastating global impact, claiming almost 2 million lives in 2020.1 Despite advances in treatment, lung cancer remains the world’s leading cause of cancer-related morbidity and mortality.
6 Mins
9 Dec 2021

Neurofibromatosis Type 1: Burden of Disease in Patients with Plexiform Neurofibromas

NF1 is an autosomal dominant disorder, arising from a mutation in the gene that encodes neurofibromin. It is a tumour-predisposing…
6 Mins
9 Dec 2021

Management and Multi-specialty Approach in the Evolving Treatment Landscape of Neurofibromatosis Type 1 Plexiform Neurofibromas

Neurofibromatosis Type 1 (NF1) is a rare disease, occurring in approximately 1 in 3,000 people. Among the numerous manifestations…
10 Mins
2 Nov 2021

Navigating the Current Treatment Landscape in Oesophageal Cancer with an Eye Toward the Future

The symposium featured three talks and a live Q&A session. First, the current patient journey and standards of care in oesophageal cancer…
16 Mins
21 Oct 2021

The Emerging Role and Value of Homologous Recombination Deficiency Testing in Advanced Ovarian Cancer: Interviews with Four Key Opinion Leaders

Ovarian cancer is the seventh most common cancer in females,1-3 and the most lethal gynaecologic malignancy globally because of its vague…
We’ve noticed you’re accessing
from North/South America.